Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

938 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment.
Imaoka H, Ikeda M, Umemoto K, Sunakawa Y, Ueno M, Ueno H, Ozaka M, Kuwahara T, Okano N, Kanai M, Hisano T, Suzuki Y, Asagi A, Shioji K, Todaka A, Tsuji K, Ikezawa K, Miki I, Komatsu Y, Akutsu N, Yamashita T, Okuyama H, Furuse J, Nagano H. Imaoka H, et al. Among authors: okuyama h. Jpn J Clin Oncol. 2023 Aug 30;53(9):764-773. doi: 10.1093/jjco/hyad062. Jpn J Clin Oncol. 2023. PMID: 37325968 Free PMC article. Review.
Early relapse of unresectable gallbladder cancer after discontinuation of gemcitabine monotherapy administered for 5 years in a patient who had complete response to the treatment.
Suyama K, Ikeda M, Suzuki E, Kojima M, Mitsunaga S, Shimizu S, Ohno I, Takahashi H, Okuyama H, Kuwahara A, Okusaka T, Furuse J. Suyama K, et al. Among authors: okuyama h. Case Rep Oncol. 2013 Oct 24;6(3):531-7. doi: 10.1159/000356080. eCollection 2013. Case Rep Oncol. 2013. PMID: 24348389 Free PMC article.
Efficacy of prophylactic minocycline treatment for skin toxicities induced by erlotinib plus gemcitabine in patients with advanced pancreatic cancer: a retrospective study.
Shinohara A, Ikeda M, Okuyama H, Kobayashi M, Funazaki H, Mitsunaga S, Shimizu S, Ohno I, Takahashi H, Ichida Y, Takahashi K, Okusaka T, Saitoh S. Shinohara A, et al. Among authors: okuyama h. Am J Clin Dermatol. 2015 Jun;16(3):221-9. doi: 10.1007/s40257-015-0116-x. Am J Clin Dermatol. 2015. PMID: 25687689
[A three-week regimen of S-1 monotherapy reduced gastrointestinal toxicity and maintained efficacy in patients with gemcitabine-refractory advanced pancreatic cancer].
Tanaka H, Mitsunaga S, Kobayashi M, Funazaki H, Katayama S, Kuwahara A, Okuyama H, Takahashi H, Ohno I, Shimizu S, Sakamoto Y, Kondo S, Morizane C, Ueno H, Okusaka T, Ochiai A, Ikeda M. Tanaka H, et al. Among authors: okuyama h. Gan To Kagaku Ryoho. 2015 Mar;42(3):313-7. Gan To Kagaku Ryoho. 2015. PMID: 25812499 Japanese.
938 results